Skip to search formSkip to main contentSkip to account menu

LEX 032

Known as: LEX032 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Serpins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
LEX032, a novel recombinant serpin, protects the brain after transient focal ischemia.
This investigation examined the effectiveness of a serine protease inhibitor (LEX032) when used as a cerebral protective agent… 
1999
1999
LEX 032: a novel recombinant human protein for the treatment of ischaemic reperfusion injury.
Reperfusion injury is defined as the enhancement of the damage that occurs in ischaemic cells during the reperfusion period… 
1998
1998
Effects of LEX032, a novel recombinant serine protease inhibitor, on N(G)-nitro-L-arginine methyl ester induced leukocyte-endothelial cell interactions.
1997
1997
Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032).
The interaction of a bioengineered serpin (LEX032) with human leukocyte proteinase 3 (PR 3) has been investigated. LEX032 was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)